Does IPILIMUMAB Cause Hospitalisation? 214 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 214 reports of Hospitalisation have been filed in association with IPILIMUMAB (YERVOY). This represents 0.6% of all adverse event reports for IPILIMUMAB.
214
Reports of Hospitalisation with IPILIMUMAB
0.6%
of all IPILIMUMAB reports
23
Deaths
210
Hospitalizations
How Dangerous Is Hospitalisation From IPILIMUMAB?
Of the 214 reports, 23 (10.7%) resulted in death, 210 (98.1%) required hospitalization, and 16 (7.5%) were considered life-threatening.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IPILIMUMAB. However, 214 reports have been filed with the FAERS database.
What Other Side Effects Does IPILIMUMAB Cause?
Death (3,710)
Malignant neoplasm progression (3,296)
Diarrhoea (2,557)
Off label use (2,097)
Colitis (1,988)
Pyrexia (1,796)
Rash (1,556)
Fatigue (1,447)
Intentional product use issue (1,329)
Nausea (1,169)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which IPILIMUMAB Alternatives Have Lower Hospitalisation Risk?
IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE
IPILIMUMAB vs IPRATROPIUM
IPILIMUMAB vs IPRATROPIUM\IPRATROPIUM ANHYDROUS
IPILIMUMAB vs IPTACOPAN
IPILIMUMAB vs IRBESARTAN